Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection

NCT02018328 is registered in ClinicalTrials.gov with Gingold Belfer Rachel as lead sponsor.

NCT NCT02018328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02018328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection
Lead sponsor
Gingold Belfer Rachel
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2014
Completion date
Not reported
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

positivity for helicobacter pylori